{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:08:05Z","timestamp":1789585685441,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH062646"],"award-info":[{"award-number":["MH062646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH124671"],"award-info":[{"award-number":["MH124671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS031373"],"award-info":[{"award-number":["NS031373"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.tips.2023.06.008","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T21:50:24Z","timestamp":1689457824000},"page":"740-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Trofinetide: a pioneering treatment for Rett syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Harrison","family":"Parent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Ferranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6009-8212","authenticated-orcid":false,"given":"Colleen","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2023.06.008_bb0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/acschemneuro.2c00675","article-title":"Concise overview of glypromate neuropeptide research: from chemistry to pharmacological applications in neurosciences","volume":"14","author":"Silva-Reis","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2023.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.06.008_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00429-014-0934-2","article-title":"IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei","volume":"221","author":"Fuentes-Santamar\u00eda","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.tips.2023.06.008_bb0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12017-013-8236-z","article-title":"Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3","volume":"15","author":"Cartagena","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.tips.2023.06.008_bb0025","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1038\/s41598-021-90517-8","article-title":"MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge","volume":"11","author":"Zalosnik","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2023.06.008_bb0030","article-title":"Illness severity, social and cognitive ability, and EEG analysis of ten patients with Rett syndrome treated with mecasermin (recombinant human IGF-1)","volume":"2016","author":"Pini","year":"2016","journal-title":"Autism Res. Treat."},{"key":"10.1016\/j.tips.2023.06.008_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.868008","article-title":"Molecular signatures of response to mecasermin in children with Rett syndrome","volume":"16","author":"Shovlin","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2023.06.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100881","article-title":"Rett syndrome: a timely review from recognition to current clinical approaches and clinical study updates","volume":"37","author":"Ivy","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.tips.2023.06.008_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity","volume":"325","author":"Dyer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2023.06.008_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/brain\/awy323","article-title":"Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder","volume":"142","author":"Banerjee","year":"2019","journal-title":"Brain"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:14:59Z","timestamp":1759050899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614723001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0165614723001359"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2023.06.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trofinetide: a pioneering treatment for Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2023.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}